Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02812290 · ClinicalTrials.gov registry record
Diagnostic and Therapeutic Applications of Microarrays in Lung Transplantation
A clinical trial of Lung Transplant Rejection, sponsored by University of Alberta.
- Recruiting
- Registry status
- 700
- Enrollment target
- 11
- Study locations
NCT02812290 is a study of Lung Transplant Rejection that is actively recruiting participants, run by University of Alberta. The registered enrollment target is 700 participants, above the 544-participant average among 6 other Lung Transplant Rejection trials with a reported enrollment target (29% higher). The trial reports 11 study locations across 7 states.
The verdict
NCT02812290, a study of Lung Transplant Rejection, is actively recruiting participants, sponsored by University of Alberta.
- RECRUITING
- Registry status
- 700 participants
- Enrollment target
- 11
- Study locations
Study Summary
Objective: To evaluate the potential impact of molecular phenotyping of transbronchial biopsies in lung transplant recipients with allograft dysfunction, and the potential for developing a safer endobronchial mucosal biopsy format.
Conditions Studied
Interventions
- PROCEDURE Lung transplant biopsy bites.
Study Locations (11)
Other
- The Alfred Hospital, Monash University - Melbourne
- Department of Thoracic Surgery, Medical University of Vienna - Vienna
- Charles University/Hospital Motol - Prague
- Thoracic Surgery Transplant Clinic - Szczecin
Alberta
- Alberta Transplant Applied Genomics Centre, University of Alberta - Edmonton
- Department of Medicine, University of Alberta - Edmonton
Arizona
- St. Joseph's Hospital and Medical Center 350 West Thomas Road, Floor 8HLT - Phoenix
Maryland
- University of Maryland School of Medicine - Baltimore
Missouri
- Division of Pulmonary and Critical Care, Washington University School of Medicine - St Louis
Texas
- University of Texas at San Antonio - San Antonio
Ontario
- University Health Network, Toronto General Hospital - Toronto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 700 participants |
| Start Date | 2016-05 |
| Est. Completion | 2026-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02812290
The ClinicalTrials.gov registry entry for NCT02812290 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 700 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 544-participant average among 6 other Lung Transplant Rejection trials with a reported enrollment target (29% higher). The listed sponsor is University of Alberta, which has 19 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Lung Transplant Rejection appearing as the primary indexed condition, and to 1 intervention - of which Lung transplant biopsy bites. is the first listed.
NCT02812290 reports 11 study locations spanning 7 distinct geographic areas - top geographies include Other, Alberta, Arizona.
Frequently Asked Questions
What is clinical trial NCT02812290 about?
NCT02812290 is a clinical study titled "Diagnostic and Therapeutic Applications of Microarrays in Lung Transplantation". Objective: To evaluate the potential impact of molecular phenotyping of transbronchial biopsies in lung transplant recipients with allograft dysfunction, and the potential for developing a safer endobronchial mucosal biopsy format.
What is the current status of trial NCT02812290?
This trial is currently recruiting. The enrollment target is 700 participants. The study started on 2016-05. Estimated completion is 2026-12.
What conditions does trial NCT02812290 study?
This clinical trial studies the following conditions: Lung Transplant Rejection.
What interventions are being tested in trial NCT02812290?
The interventions under investigation include: Lung transplant biopsy bites. (PROCEDURE).
Who is sponsoring clinical trial NCT02812290?
This trial is sponsored by University of Alberta, which has 19 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02812290 being conducted?
This trial has 11 study locations across Arizona, Maryland, Missouri, Texas, Alberta. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Transplant Rejection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Prospective Multicenter Research on Donor and Recipient Management Strategies to Improve Lung Transplant Outcomes
RECRUITING
-
Developing Hyperpolarized Gas MRI Signatures to Detect and Manage Acute Cellular Rejection
RECRUITING · Phase 2
-
A Study to Test How Effective Belumosudil Tablets Are for Treating Adult Participants With Chronic Lung Allograft Dysfunction
RECRUITING · Phase 3
-
Cryoprobe Biopsy and Chronic Rejection in Lung Transplant Recipients
RECRUITING · NA
-
LAMBDA 002 (Lung Registry) Study
ACTIVE NOT RECRUITING
-
Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Double Lung Transplant (BOSTON-2)
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.